Venn Life Sciences Holdings PLC (LSE:VENN) - Share price - Overview

Stock Report

Venn Life Sciences Holdings PLC VENN

Last Price
GBX13.75

Day Change
0.00|0.00%

As of 22/06/2017
15:41:27 BST | GBX
Minimum 15 Minutes Delay.

Last Close13.75p
Day Range13.58 - 14.00
Mkt Cap8.29Mil
52-Wk Range13.00 - 30.30
Yield %0.00
ISINGB00B9275X97
Volume67,523
P/E-15.97
P/S0.56
P/CF-60.04

Share Price

Total Returns 23/06/2017

 Chg (%)  
More ...
Venn Life Sciences Holdings PLC-7.56 
FTSE 100 TR GBP-0.50
 
Financials
201420152016
More ...
Income Statement
Turnover3.968.3314.67
Operating Profit-1.440.17-0.46
Net Profit-1.470.19-0.61
Reported EPS-4.870.03-0.93
Balance Sheet
Current Assets2.296.916.82
Non Current Assets2.384.315.74
Total Assets4.6711.2212.56
Current Liabilities3.193.653.63
Total Liabilities3.263.683.66
Total Equity1.417.548.91
Cash Flow
Operating Cash Flow-0.81-1.65-0.18
Net Change in Cash0.312.33-0.21
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
20171.101.58-8.69---
20181.361.7913.147.680.58--
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
01/11/2016PurchaseAllan Wood21.73165,00035,855.00
31/10/2016PurchaseAllan Wood21.5065,00013,975.00

Company Profile

Venn Life Sciences Holdings PLC is a Clinical Research Organization. The Company provides consulting and clinical trial services to pharmaceutical, biotechnology and medical device organizations.

Sector

Medical Care

Market Position

1560 of 1843 Companies

Index

FTSE AIM All Share

Outlook

(31/03/2017) ceo - "Our industry sector continues to deliver good growth and clear opportunities exist for Venn to grow both organically and through acquisition"

Next Event 28/09/2017

Next interim announcement
Ratios
CompSecMkt
More ...
PER (E)8.1820.8116.88
Div Yld (E)0.001.574.13
PEG (E)0.02-0.331.19
ROCE-12.6119.16209.80
Op Mrgn-2.434.06-99.88
EPS Grwth478.37113.2933.48
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanAllan Wood
Chief Executive OfficerMr. Tony Richardson
Chief Financial OfficerJonathan Hartshorn
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.